Literature DB >> 16928354

Mechanisms and models of alpha-synuclein-related neurodegeneration.

Wolfdieter Springer1, Philipp J Kahle.   

Abstract

Expression of the Parkinson's disease-associated protein alpha-synuclein causes formation of aggregates and cytotoxicity in a great diversity of transgenic model organisms, in the case of Drosophila melanogaster affecting specific dopaminergic neuron clusters. The relative contribution of alpha-synuclein misfolding and phosphorylation for neurodegeneration was elucidated in these systems. In transgenic mice, typical neuropathologic inclusions formed concomitant with behavioral deficits, reminiscent of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Neuronal degeneration was cell-autonomous in the Lewy body disease models, whereas gliotic changes accompanied neurodegeneration caused by (oligodendro)glial cytoplasmic inclusions. These recent findings provided major insights into the molecular mechanisms of alpha-synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928354     DOI: 10.1007/s11910-996-0025-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  46 in total

1.  Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.

Authors:  Y Matsuoka; M Vila; S Lincoln; A McCormack; M Picciano; J LaFrancois; X Yu; D Dickson; W J Langston; E McGowan; M Farrer; J Hardy; K Duff; S Przedborski; D A Di Monte
Journal:  Neurobiol Dis       Date:  2001-06       Impact factor: 5.996

2.  Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.

Authors:  Philipp J Kahle; Manuela Neumann; Laurence Ozmen; Veronika Muller; Helmut Jacobsen; Will Spooren; Babette Fuss; Barbara Mallon; Wendy B Macklin; Hideo Fujiwara; Masato Hasegawa; Takeshi Iwatsubo; Hans A Kretzschmar; Christian Haass
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

3.  Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.

Authors:  Eric K Richfield; Mona J Thiruchelvam; Deborah A Cory-Slechta; Charles Wuertzer; Raul R Gainetdinov; Marc G Caron; Donato A Di Monte; Howard J Federoff
Journal:  Exp Neurol       Date:  2002-05       Impact factor: 5.330

4.  Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.

Authors:  Todd R Flower; Liudmila S Chesnokova; Clifford A Froelich; Cheryl Dixon; Stephan N Witt
Journal:  J Mol Biol       Date:  2005-09-02       Impact factor: 5.469

5.  Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.

Authors:  P J Kahle; M Neumann; L Ozmen; V Muller; H Jacobsen; A Schindzielorz; M Okochi; U Leimer; H van Der Putten; A Probst; E Kremmer; H A Kretzschmar; C Haass
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

6.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.

Authors:  Sreeganga Chandra; Gilbert Gallardo; Rafael Fernández-Chacón; Oliver M Schlüter; Thomas C Südhof
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

7.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

8.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein.

Authors:  Merja Lakso; Suvi Vartiainen; Anu-Maarit Moilanen; Jouni Sirviö; James H Thomas; Richard Nass; Randy D Blakely; Garry Wong
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

Review 10.  The synucleins.

Authors:  Julia M George
Journal:  Genome Biol       Date:  2001-12-20       Impact factor: 13.583

View more
  6 in total

1.  Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.

Authors:  Nanping Wu; Prasad R Joshi; Carlos Cepeda; Eliezer Masliah; Michael S Levine
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

Review 2.  In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?

Authors:  Marie-Francoise Chesselet
Journal:  Exp Neurol       Date:  2007-08-23       Impact factor: 5.330

3.  Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.

Authors:  Nikolaus R McFarland; Zhanyun Fan; Kui Xu; Michael A Schwarzschild; Mel B Feany; Bradley T Hyman; Pamela J McLean
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

4.  Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention.

Authors:  Aaron Carman; Sarah Kishinevsky; John Koren; Wenjie Lou; Gabriela Chiosis
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-04

5.  Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.

Authors:  Ian Casci; Karthik Krishnamurthy; Sukhleen Kour; Vadreenath Tripathy; Nandini Ramesh; Eric N Anderson; Lara Marrone; Rogan A Grant; Stacie Oliver; Lauren Gochenaur; Krishani Patel; Jared Sterneckert; Amanda M Gleixner; Christopher J Donnelly; Marc-David Ruepp; Antonella M Sini; Emanuela Zuccaro; Maria Pennuto; Piera Pasinelli; Udai Bhan Pandey
Journal:  Nat Commun       Date:  2019-12-06       Impact factor: 14.919

6.  Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein.

Authors:  Natalia Ninkina; Owen Peters; Steven Millership; Hatem Salem; Herman van der Putten; Vladimir L Buchman
Journal:  Hum Mol Genet       Date:  2009-02-26       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.